Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
38.13
-5.13 (-11.86%)
At close: Nov 17, 2025, 4:00 PM EST
38.13
0.00 (0.00%)
After-hours: Nov 17, 2025, 4:10 PM EST
Claritev Market Cap
Claritev has a market cap or net worth of $630.12 million as of November 17, 2025. Its market cap has increased by 324.28% in one year.
Market Cap
630.12M
Enterprise Value
5.25B
1-Year Change
324.28%
Ranking
Category
Stock Price
$38.13
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $630.12M, an increase of 159.31%. That is a compound annual growth rate of 18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 714.90M | 199.11% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |